tiprankstipranks
Advertisement
Advertisement

AMPH Stock Latest News

Amphastar price target lowered to $23 from $30 at Barclays
The FlyAmphastar price target lowered to $23 from $30 at Barclays
5d ago
AMPH
Amphastar Expands Share Repurchase Authorization to Manage Equity
PremiumCompany Announcements
Amphastar Expands Share Repurchase Authorization to Manage Equity
27d ago
8K
AMPH
Amphastar Updates Executive Employment Agreements to Strengthen Leadership
PremiumCompany Announcements
Amphastar Updates Executive Employment Agreements to Strengthen Leadership
1M ago
8K
AMPH
Amphastar Pharmaceuticals Balances Growth Plans With Margin Risks
PremiumCompany Announcements
Amphastar Pharmaceuticals Balances Growth Plans With Margin Risks
1M ago
AMPH
Amphastar price target lowered to $30 from $34 at Wells Fargo
PremiumThe Fly
Amphastar price target lowered to $30 from $34 at Wells Fargo
1M ago
AMPH
Amphastar reports Q4 EPS 73c, consensus 92c
PremiumThe FlyAmphastar reports Q4 EPS 73c, consensus 92c
2M ago
AMPH
Amphastar gets FDA approval for Ipratropium Bromide HFA Inhalation Aerosol ANDA
Premium
The Fly
Amphastar gets FDA approval for Ipratropium Bromide HFA Inhalation Aerosol ANDA
2M ago
AMPH
AMPH Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
AMPH Upcoming Earnings Report: What to Expect?
2M ago
AMPH
Amphastar Licenses ACTH Analog AMP-110 for North America
PremiumCompany Announcements
Amphastar Licenses ACTH Analog AMP-110 for North America
3M ago
8K
AMPH
Amphastar price target lowered to $30 from $31 at BofA
PremiumThe Fly
Amphastar price target lowered to $30 from $31 at BofA
3M ago
AMPH
Amphastar Pharmaceuticals Receives Buy Rating Following FDA Approval of AMP-015
PremiumRatings
Amphastar Pharmaceuticals Receives Buy Rating Following FDA Approval of AMP-015
4M ago
AMPH
Amphastar announces FDA approval for teriparatide injection
PremiumThe Fly
Amphastar announces FDA approval for teriparatide injection
4M ago
AMPH
Amphastar initiated with an Equal Weight at Barclays
PremiumThe FlyAmphastar initiated with an Equal Weight at Barclays
4M ago
AMPH
Amphastar Pharmaceuticals’ Resilient Q3 2025 Earnings Call
Premium
Company Announcements
Amphastar Pharmaceuticals’ Resilient Q3 2025 Earnings Call
5M ago
AMPH
Amphastar Pharmaceuticals: Strong Q3 Performance and Promising Pipeline Justify Buy Rating
Premium
Ratings
Amphastar Pharmaceuticals: Strong Q3 Performance and Promising Pipeline Justify Buy Rating
5M ago
AMPH
Amphastar Pharmaceuticals Reports Q3 2025 Earnings
PremiumCompany Announcements
Amphastar Pharmaceuticals Reports Q3 2025 Earnings
5M ago
AMPH
Amphastar reports Q3 adjusted EPS 93c, consensus 83c
PremiumThe Fly
Amphastar reports Q3 adjusted EPS 93c, consensus 83c
5M ago
AMPH
AMPH Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
AMPH Upcoming Earnings Report: What to Expect?
5M ago
AMPH
Amphastar Expands BAQSIMI® Distribution in Asia
PremiumCompany Announcements
Amphastar Expands BAQSIMI® Distribution in Asia
6M ago
8K
AMPH
Amphastar Pharmaceuticals: Strategic Shift and Growth Catalysts Justify Buy Rating with $36 Target
PremiumRatingsAmphastar Pharmaceuticals: Strategic Shift and Growth Catalysts Justify Buy Rating with $36 Target
6M ago
AMPH
Amphastar price target lowered to $31 from $32 at BofA
Premium
The Fly
Amphastar price target lowered to $31 from $32 at BofA
6M ago
AMPH
Amphastar Signs $2.8M Research Agreement with Hanxin
Premium
Company Announcements
Amphastar Signs $2.8M Research Agreement with Hanxin
7M ago
8K
AMPH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >